Back
Ascendis Pharma A/S Stock Predictions
This Critical Mineral's Up 122% in the Last 12 Months.
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
46
ASND
Ascendis Pharma A/S
Last Price:
$222.23
Seasonality Move:
6.98%
7 Day Trial
ALL ACCESS PASS
$
7
Most Pre-IPO Big Tech Shifts Look Like This at the Start
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.comAscendis Pharma A/S Stock Forecast
-
Over the next 52 weeks, Ascendis Pharma A/S has on average historically risen by 36.2% based on the past 10 years of stock performance.
-
Ascendis Pharma A/S has risen higher in 8 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
-
Is Ascendis Pharma A/S Stock Undervalued?The current Ascendis Pharma A/S [ASND] share price is $217.38. The Score for ASND is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Ascendis Pharma A/S Stock Go Up Next Year?
-
Over the next 52 weeks, Ascendis Pharma A/S has on average historically risen by 36.2% based on the past 10 years of stock performance.
Ascendis Pharma A/S Stock Rating
Sell
46
Ascendis Pharma A/S (ASND)
is a Sell
Is Ascendis Pharma A/S overpriced?
-
Ascendis Pharma A/S has risen higher in 8 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
Ascendis Pharma A/S Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ascendispharma.com
52-Week Data
52-Week High:
242.00
52-Week Low:
118.03
Prediction Charts
Market Cap:
13.3B
Price in USD:
217.38
Volume:
1.3M
Beta:
0.59
Technical Analysis
SMA50:
212.99
SMA100:
207.94
SMA200:
191.76
52-Wk Change:
67.98%
Stock Predictions
-
Is Ascendis Pharma A/S stock public?Yes, Ascendis Pharma A/S is a publicly traded company.
-
What is the Ascendis Pharma A/S stock quote today?The Ascendis Pharma A/S stock price is 217.38 USD today.
-
How to buy Ascendis Pharma A/S stock online?You can buy Ascendis Pharma A/S shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-16 | 214.35 | 205.83 | 217.00 | 205.52 |
| Jan-20 | 203.51 | 215.58 | 216.18 | 200.69 |
| Jan-21 | 213.90 | 216.66 | 217.00 | 209.79 |
| Jan-22 | 214.87 | 228.65 | 236.25 | 214.27 |
| Jan-23 | 228.66 | 235.39 | 238.84 | 228.46 |
| Jan-26 | 234.59 | 233.65 | 235.79 | 229.00 |
| Jan-27 | 233.99 | 238.80 | 239.65 | 232.83 |
| Jan-28 | 238.69 | 222.45 | 242.00 | 221.86 |
| Jan-29 | 222.26 | 223.95 | 227.34 | 220.53 |
| Jan-30 | 224.00 | 226.10 | 228.51 | 221.52 |
| Feb-2 | 225.67 | 223.59 | 230.68 | 222.00 |
| Feb-3 | 223.78 | 224.67 | 227.95 | 222.21 |
| Feb-4 | 223.66 | 219.73 | 225.90 | 216.71 |
| Feb-5 | 220.31 | 217.38 | 227.18 | 215.51 |
Ascendis Pharma A/S Earnings
Ascendis Pharma A/S Earnings Report: Per Share Ascendis Pharma A/S Earnings Q1 Q2 Q3 and Q4 last year and next year.
Ascendis Pharma A/S Forecast Revenue Growth
Ascendis Pharma A/S Stock Analysis: Historical quarterly revenues per share for Ascendis Pharma A/S and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $1.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.79 per share, and an increase next year of $7.04 per share.
* Ascendis Pharma A/S stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.